The worse prognosis and increased endocrine resistance of MKShi/ERSlo tumours cannot be explained by different ER expression in immunohistochemistry, as the ER expression of these tumours in TCGA was not significantly different from that of MKShi/ERShi tumours (Supplementary Fig. S6). Here, ESR1 is linked to neoplasm.